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A Retrospective Study of Laboratory-Based Enteric Fever 
Surveillance, Pakistan, 2012–2014
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1Department of Paediatrics & Child Health, and 2Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan; 3Coalition Against Typhoid, Sabin 
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Introduction. The Surveillance for Enteric Fever in Asia Project (SEAP) is a multisite surveillance study designed to capture 
morbidity and mortality burden of enteric fever (typhoid and paratyphoid) in Bangladesh, Nepal, and Pakistan. We aim to describe 
enteric fever disease burden, severity of illness, and antimicrobial resistance trends in Pakistan.
Methods. In this retrospective, cross-sectional study, laboratory records of hospitalized patients who received a blood culture in 
any of 3 Aga Khan University hospitals in Karachi and Hyderabad, Pakistan, from 2012 to 2014 were reviewed. A case was defined 
as having a positive blood culture for Salmonella Typhi (S. Typhi) or Salmonella Paratyphi (S. Paratyphi). Antimicrobial sensitivity 
patterns were characterized for all S. Typhi and S. Paratyphi isolates. Medical records were available for abstraction (demographics, 
clinical features, complications) only among hospitalized cases.
Results. Of the 133 017 blood cultures completed during the study period, 2872 (2%) were positive—1979 (69%) for S. Typhi 
and 893 (31%) for S. Paratyphi. Fluoroquinolone resistance was present in >90% of both the S. Typhi and the S. Paratyphi isolates; 
almost none of the isolates were resistant to cephalosporins. Multidrug resistance (resistance to ampicillin, chloramphenicol, and 
cotrimoxazole) was observed in 1035 (52%) S. Typhi isolates and 14 (2%) S. Paratyphi isolates. Among S. Typhi and S. Paratyphi 
isolates, 666 (23%) were linked to hospitalized patients with medical records. Of the 537 hospitalized S. Typhi cases, 280 (52%) were 
aged 5–15 years, 133 (25%) were aged 2–4 years, 114 (21%) were aged >15 years, and 10 (2%) were aged 0–1 years. Among the 129 
hospitalized S. Paratyphi cases, 73 (57%) were aged >15 years, 41 (32%) were aged 5–15 years, 13 (10%) were aged 2–4 years, and 
2 (2%) were aged 0–1 years. Significant differences in symptomology between S. Typhi and S. Paratyphi cases were observed for 
nausea/vomiting, diarrhea, loss of appetite, and headache. Leukopenia, thrombocytopenia, and encephalopathy were the most com-
monly reported complications among enteric fever cases. No deaths were reported.
Conclusion. Evidence of high antimicrobial resistance levels and disease severity support the need for continued surveillance 
and improved diagnostics for typhoid. Further prospective studies on vaccination as a tool for prevention of enteric fever in Pakistan 
are needed to inform disease intervention strategies.
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Globally, typhoid and paratyphoid fever (2 similar illnesses 
that constitute “enteric fever”) have been estimated to cause 
190 000 deaths annually [1]. More than 90% of enteric fever–
related morbidity and mortality is reported from Asia, and 
studies from some Asian countries have shown that incidence 
of typhoid fever is highest among children aged <15 years [2, 3]. 
Because of a similar clinical presentation with other febrile ill-
nesses, the utility of clinical diagnoses in enteric fever surveil-
lance and disease burden estimation remains limited. Recent 
estimates of blood culture–confirmed cases are not available to 
calculate the incidence and disease severity of enteric fever in 
Pakistan [4]. Additionally, the rise in antibiotic-resistant strains 
of Salmonella Typhi (S. Typhi) and Salmonella Paratyphi (S. 
Paratyphi) has been associated with increased morbidity, mor-
tality, and treatment costs [2, 3, 5, 6].
Existing studies have not provided reliable or recent popu-
lation-based estimates to understand enteric fever disease bur-
den and severity in South Asia. Data gathered from small-scale 
studies, such as hospital case reviews, are often focus on disease 
incidence in urban areas and are prone to spectrum bias focus-
ing on severe cases, which has limited generalizability [3]. In 
Karachi from 1999 to 2001, passive surveillance at 2 field sites 
was used to estimate the annual serological incidence rate of 
typhoid to be 710 per 100 000, whereas the annual incidence 
rate for blood culture–confirmed cases was estimated at 170 per 
100 000 [4]. The absence of credible estimates of the burden and 
severity of enteric fever has limited understanding of the impact 
of the disease and, therefore, hampers momentum for preven-
tion and control efforts.
A substantial need remains to understand the changing 
enteric fever antimicrobial resistance trends in South Asia. 
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Wong and colleagues describe a phylogeographical analysis 
that identified recent transfers and spread throughout Africa 
and Asia of a multidrug-resistant H58 lineage of S. Typhi [7]. 
Without additional understanding of the mechanism of drug 
resistance and development of strategies to control for resis-
tance, treatment options for enteric fever are likely to become 
obsolete [8]. As part of the Surveillance for Enteric Fever in 
Asia Project (SEAP), this study aims to provide retrospective 
evidence on enteric fever disease burden, illness severity, and 
antimicrobial resistance trends in Pakistan.
MATERIAL AND METHODS
Study Sites
Hospitals in Karachi and Hyderabad, Pakistan, were assessed 
for study eligibility, which included having hospital labora-
tory blood culture capabilities and a systematic mechanism 
for capturing, archiving, and retrieving medical record data. 
Among the 8 hospitals assessed, 3 were eligible and partic-
ipated in the study. Aga Khan University Hospital, located 
in Karachi, is a 700-bed tertiary-care hospital with approx-
imately 61 000 annual admissions in a catchment area of 23 
million persons. Aga Khan Hospital for Women and Children, 
located in Karachi, is a 48-bed secondary-care hospital with 
approximately 2500 annual admissions in a catchment area of 
approximately 75 000 persons. Aga Khan Hospital Hyderabad, 
located in Hyderabad, is an 87-bed secondary-care hospital 
with approximately 6500 annual admissions in a catchment 
are of approximately half a million persons. Both Aga Khan 
Hospital for Women and Children and Aga Khan Hospital 
Hyderabad provide care for only women and children. All Aga 
Khan University hospitals have centralized electronic medical 
and laboratory record databases that use unique identification 
numbers. The hospital labs have standardized blood culture 
techniques that use an automated culture system (culture con-
tamination rate: <2%).
Case Selection and Data Abstraction
The laboratory database was queried to identify all records 
with a blood culture positive for S. Typhi or S. Paratyphi from 
January 2012 to December 2014. For reporting of trends, all 
positive blood isolates were included; multiple positive labo-
ratory records obtained from a single patient were excluded. 
Sensitivity testing at the lab follows Clinical and Laboratory 
Standards Institute guidelines. Antimicrobial resistance data 
patterns were abstracted, including those for ampicillin, chlo-
ramphenicol, cotrimoxazole, ciprofloxacin, cefixime, and cef-
triaxone. Laboratory records were matched to medical records 
from hospitalized patients using unique identification numbers. 
Data abstracted from medical records included (1) demograph-
ics, (2) clinical presentation, (3) disease complications, (4) clin-
ical investigations, and (5) diagnosis and patient outcomes.
Data Management and Analysis
Data were collected on tablets with standardized forms and 
transferred daily to a server. A 10% quality control of all study 
records was conducted. The descriptive data analysis used SPSS 
version 20.0 (Armonk, New York). Multidrug resistance was 
defined as resistance to ampicillin, chloramphenicol, and cotri-
moxazole [9]. Proportions of symptoms at the time of presenta-
tion were compared between patients with S. Typhi and patients 
with S. Paratyphi using Pearson χ2 tests. P values less than .05 
were considered statistically significant.
Ethical Considerations
The study was approved as nonresearch and exempted from a 
full ethical review by the Ethical Review Committee of the Aga 
Khan University, Karachi, Pakistan.
RESULTS
From among the 133 017 blood cultures available from lab 
records at the study sites from 2012 to 2014, 2872 (2%) were 
positive for enteric fever, including 1979 (69%) that were 
positive for S. Typhi and 893 (31%) that were positive for S. 
Paratyphi. The percentage of total culture-positive enteric fever 
cases that were S. Typhi increased from 67% (n = 584) in 2012 
to 68% (n = 654) in 2013 and 72% (n = 690) in 2014.
There was a decreasing trend of resistance to ampicillin, chlo-
ramphenicol, and cotrimaxazole from 2012 to 2014 (Table 1). 
Resistance to ciprofloxacin was 93% in 2012, which slightly 
decreased to 90% in 2014. Although resistance to ceftriaxone 
was extremely low in our study population, there was a slight 
increase from 0.1% in 2013 to 0.3% in 2014 (Table 1).
During the study period, elevated antimicrobial resistance 
was identified in S. Typhi isolates against ampicillin (55%), 
chloramphenicol (55%), and cotrimoxazole (56%); however, 
minimal resistance to all 3 antibiotics (≤3%) was observed 
in S. Paratyphi isolates (Figure  1, Table  1). Enteric fever iso-
lates were almost entirely (>99%) sensitive to cephalosporins. 
Although resistance to ciprofloxacin has remained relatively 
stable at approximately 93% among S. Paratyphi isolates, a slight 
decrease in resistance has been observed from 94% to 88% in 
S. Typhi isolates from 2012 to 2014 (Figure 2). A decrease in 
multidrug resistance was observed from 2012 to 2014 and was 
driven by reduction in the resistance to ampicillin, chloram-
phenicol, and cotrimaxazole among S. Typhi isolates.
Among all enteric fever blood culture–positive cases, 2206 
(77%) were outpatients and 666 (23%) were hospitalized. Most 
(55%) hospitalized enteric fever cases received care in pediat-
ric wards (Table 2). A provisional diagnosis of enteric fever was 
provided to 86% of blood culture–confirmed enteric fever cases. 
Among the 537 hospitalized cases of S. Typhi, 353 (66%) were 
males. Similarly, males accounted for 58% of the 129 hospital-
ized S. Paratyphi cases. Comparable percentages were observed 
for cases among infants aged ≤1 year for S. Typhi (1.9%) and 
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S. Paratyphi (1.6%). However, S. Typhi case patients were gener-
ally younger, with 79% aged ≤15 years compared with 43% of S. 
Paratyphi cases. Among enteric fever cases, the most commonly 
reported symptoms were fever (97%), nausea/vomiting (40%), 
and diarrhea (26%). Salmonella Typhi cases were more likely 
to have reported nausea/vomiting, diarrhea, and anorexia com-
pared with S. Paratyphi cases (P  <  .01). Salmonella Paratyphi 
cases were more likely to have reported a headache (P <  .05). 
Leukopenia was the most common complication, affecting 11% 
of S. Typhi cases and 16% of S. Paratyphi cases. Two cases of 
intestinal perforation were observed, 1 for each S. Typhi and S. 
Paratyphi. Encephalopathy was observed in 5 (0.9%) S. Typhi 
cases and 1 S. Paratyphi (0.8%) case. No deaths were recorded, 
and most cases of enteric fever were discharged, with <1% of 
cases requiring transfer to another hospital.
DISCUSSION
This study provides critical information on burden, antimicrobial 
resistance trends, and illness severity of enteric fever in Pakistan 
from 2012 to 2014. The number of blood culture–confirmed 
cases reported in this study exceeds those reported in the same 
hospitals from 2009 to 2011 [10]. The highest proportion of 
typhoid cases were children aged 5–15 years, with more males 
than females affected. Our results are consistent with studies 
from Vietnam, where incidence of typhoid fever was highest 
among children aged 5–9 years [11] but diverge from some of 
the studies from India and Bangladesh that found the highest 
incidence of typhoid among children <5 years old [11].
The findings in our retrospective study raise several con-
cerns about antimicrobial resistance; however, none are as 
alarming as the high prevalence of resistance to ciprofloxa-
cin. Although no longer the standard of treatment for enteric 
fever in South Asia, fluoroquinolones (ciprofloxacin) continue 
to be preferentially prescribed in Pakistan. Without a rapid 
diagnostic test to guide physicians in the diagnosis of enteric 
fever, appropriate treatment of enteric fever will continue 
Table 1. Proportion of Salmonella Typhi and Salmonella Paratyphi Isolates Resistant to Various Antibiotics From Aga Khan University Hospitals, Karachi 
and Hyderabad, Pakistan, by Year and Overall, 2012–2014
Ampicillin Chloramphenicol Ciprofloxacin Ceftriaxone Cotrimaxazole MDR
Year No. (%)  No. (%) No. (%) No. (%) No. (%) No. (%)
Salmonella Typhia
2012 375/584 (64) 384/585 (66) 549/586 (94) 0/585 (0) 385/586 (66) 365/584 (63)
2013 339/654 (52) 355/681 (52) 602/677 (89) 1/667 (0.1) 359/681 (53) 332/675 (49)
2014 344/689 (50) 350/706 (50) 626/707 (86) 3/706 (0.4) 356/708 (50) 338/702 (48)
Total 1058/1927 (55) 1089/1972 (55) 1777/1970 (90) 4/1958 (0.2) 1100/1975 (56) 1035/1961 (53)
Salmonella Paratyphi
2012 8/294 (3) 7/302 (2) 281/303 (93) 0/301 (0) 7/302 (2) 4/301 (1)
2013 10/304 (3) 10/314 (3) 290/313 (93) 0/308 (0) 12/314 (4) 5/311 (2)
2014 6/273 (2) 8/274 (3) 256/276 (93) 0/275 (0) 8/274 (3) 5/274 (2)
Total 24/871 (3) 25/890 (3) 827/892 (93) 0/884 (0) 27/890 (3) 14/886 (2)
Abbreviation: MDR, multidrug resistance (resistant to ampicillin, chloramphenicol, and cotrimoxazole).
aA total of 4 (0.2%) Salmonella Typhi isolates were resistant to cefixime, including 1 (<0.1%) in 2012, 1 (<0.1%) in 2013, and 2 (0.1%) in 2014.
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Figure  1. Antimicrobial resistance patterns among Salmonella Typhi and 
Salmonella Paratyphi isolates at Aga Khan University Hospitals, Karachi and 
Hyderabad, Pakistan, 2012–2014. Abbreviation: MDR, multidrug resistance.
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Figure  2. Ciprofloxacin resistance among Salmonella Typhi and Salmonella 
Paratyphi isolates at Aga Khan University Hospitals, by year, Karachi and Hyderabad, 
Pakistan, 2012–2014.
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to be difficult, resulting in treatment failures. The standard 
treatments for enteric fever currently include cefixime and 
ceftriaxone [12]. Although a minimal level of resistance to 
cephalosporins was observed during the study period, antibi-
otic stewardship efforts will be imperative to retain the effec-
tiveness of these disease treatment options. These concerns 
have already been realized in a recently reported outbreak of 
ceftriaxone-resistant S. Typhi in the Hyderabad city of Sindh, 
Pakistan, in 2017. During the first 6 months of the outbreak, 
>300 persons were identified by blood culture to be infected 
with S. Typhi resistant to first-line antibiotics (ampicillin, chlo-
roamphenicol, and cotimaxazole) and ceftriaxone but sensi-
tive to meropenem and azithromycin [8]. First-line antibiotics 
that make up the classification of multidrug resistance are no 
longer the choice of treatment for enteric fever. Decreased use 
of first-line drugs for enteric fever has likely contributed to the 
continued reduction in multidrug resistance in Pakistan [10].
Our results are consistent with a recent systematic review 
of enteric fever literature [13], which shows a high burden of 
disease in South Asia and finds that complications other than 
intestinal perforation are a frequent occurrence. A study con-
ducted at a public-sector hospital in Pakistan reported 32 intes-
tinal perforations over a 33-month period [14]. The prevalence 
of intestinal perforation is likely underestimated in this study 
because their inclusion criterion was a positive blood culture 
for an enteric fever pathogen. There are several reasons why 
patients with an intestinal perforation may not have a positive 
blood culture, such as failure to obtain a blood culture or pre-
surgical antibiotic therapy prior to blood collection. In addi-
tion, because the study hospitals in this analysis are private, 
the cost of surgery may be prohibitive, resulting in intestinal 
perforation cases self-diverting to other hospitals for care. This 
study highlights that, although intestinal perforation is a hall-
mark complication of enteric fever, other complications, such as 
encephalopathy, are relatively common.
This retrospective study has several limitations; these will in 
part be addressed by a subsequent prospective SEAP study in 
Pakistan. First, the study design does not fully allow for disease 
burden to be estimated or incidence to be calculated. The dis-
ease burden in our study is underestimated due to absence of 
community because this was a hospital-based survey [12], the 
private hospital population is dissimilar to the community, only 
patients who had a blood culture were included in the study, 
and blood culture testing was used, which has a low sensitivity 
(40%–60%). Phylogenetic analysis was not conducted on any of 
the isolates reviewed in this study. Although the study provides 
evidence on retrospective antibiotic resistance trends, analysis 
to understand transmission patterns of S. Typhi with resistant 
genetic traits in Pakistan was unavailable. In particular, under-
standing the impact of S. Typhi H58 [15–17] and other resistant 
strains will be of future importance in maintaining effective 
treatment. Finally, the full spectrum of disease severity could 
Table 2. Demographic and Clinical Characteristics of Patients Admitted 
With Blood Culture–Confirmed Enteric Fever at Aga Khan University 
Hospitals, Karachi and Hyderabad, Pakistan, 2012–2014
Characteristics of patients
Typhoid  
fever
Paratyphoid 
fever
No. % No. %
No. 537 129
Sex
 Male 353 65.7 75 58.1
 Female 184 34.3 54 41.9
Age
 0–1 y 10 1.9 2 1.6
 2–4 y 133 24.8 13 10.1
 5–15 y 280 52.1 41 31.8
 >15 y 114 21.2 73 56.6
Location of patient admission
 Medical 54 10.1 25 19.4
 Pediatric 334 62.2 32 24.8
 Surgical 12 2.2 12 9.3
 Emergency 128 23.8 54 41.9
 Other 9 1.7 6 4.7
Symptoms at the time of presentation
 Fever 522 97.2 121 93.8
 Nausea/vomiting* 228 42.5 37 28.7
 Diarrhea* 153 28.5 22 17.1
 Abdominal pain 109 20.3 34 26.4
 Cough/difficulty breathing 97 18.1 22 17.1
 Loss of appetite/low intake* 102 19.0 10 7.8
 General weakness 42 7.8 16 12.4
 Headache** 32 6.0 14 10.9
 Sore throat/flu 25 4.7 3 2.3
 Seizures 19 3.5 3 2.3
 Constipation 9 1.7 2 1.6
 Other 82 15.3 26 20.2
Provisional diagnosis
 Enteric fever 462 86.5 108 83.7
 Acute febrile illness 22 4.1 5 3.9
 Pneumonia/RTI 17 3.2 5 3.9
 UTI 6 1.1 0 0
 Other 30 5.6 11 8.5
Complications
 Leukopeniaa 61 11.4 20 15.5
 Thrombocytopeniab 7 1.3 3 2.3
 Encephalopathy 5 0.9 1 0.8
 Hepatitis 3 0.6 1 0.8
 Intestinal perforation 1 0.2 1 0.8
 Hemodynamic shock 2 0.4 0 0
 Renal impairment 1 0.2 0 0
 Other 6 1.1 2 1.6
Outcome
 Sent home 505 94.0 121 93.8
 Referred to another hospital 5 0.9 0  0
 LAMA 18 3.4 5 3.9
 Other 9 1.7 3 2.3
*Statistically significant result (P < .01) in the comparison between typhoid and paratyphoid 
patients.
**Statistically significant result (P < .05) in the comparison between typhoid and paraty-
phoid patients.
Abbreviations: LAMA, left against medical advice; RTI, respiratory tract infection; UTI, uri-
nary tract infection.
aLeukopenia was defined as reduced white blood cell count (<5000 per microliter of blood). 
bThrombocytopenia was defined as reduced platelet count (<50 000 per microliter of blood). 
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not be captured because data were only abstracted from medical 
records. Future studies will need to assess long-term follow-up 
to capture all related disease complications and the associated 
social and economic impacts.
Evidence of high antimicrobial resistance levels and dis-
ease severity support the need for continued surveillance and 
improved diagnostics for typhoid. Further prospective stud-
ies on vaccination as a tool for prevention of enteric fever in 
Pakistan are needed to inform disease intervention strategies.
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